Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger M Nef

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Heart (British Cardiac Society)|September 25, 2007
Tako-tsubo cardiomyopathy (apical ballooning)Holger M Nef, Helge Möllmann, Albrecht Elsässer
Cardiovascular Research|June 19, 2010
'Turning the right screw': targeting the interleukin-6 receptor to reduce unfavourable tissue remodelling after myocardial infarctionHelge Möllmann, Holger M Nef, Christian Troidl
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 21, 2013
Single-side renal sympathetic denervation in a hypertensive patient with a single kidneyOliver Dörr, Christian Hamm, Holger M Nef
Journal of the American College of Cardiology|December 16, 2014
Current status of bioresorbable scaffolds in the treatment of coronary artery diseaseJens Wiebe, Holger M Nef, Christian W Hamm
Current Opinion in Cardiology|October 9, 2015
Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers resultsJens Wiebe, Christian W Hamm, Holger M Nef
European Heart Journal|September 30, 2010
Anticoagulation in percutaneous coronary interventions: no man's land?Holger M Nef, Helge Möllmann, Christian W Hamm
European Heart Journal|September 12, 2013
Troponin: more lessons to learnChristoph Liebetrau, Holger M Nef, Christian W Hamm
Heart (British Cardiac Society)|June 12, 2010
Clinical pharmacology: antiplatelet therapy during surgeryHelge Möllmann, Holger M Nef, Christian W Hamm
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 17, 2016
Thebesian veins as drainage to the ventricle: A case reportNiklas F Boeder, Holger M Nef, Timm Bauer
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 21, 2023
DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIODAPTOR-RCTShigeru Saito, Holger M Nef, Mark Webster, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Heart (British Cardiac Society)|September 25, 2007
Tako-tsubo cardiomyopathy (apical ballooning)Holger M Nef, Helge Möllmann, Albrecht Elsässer
Cardiovascular Research|June 19, 2010
'Turning the right screw': targeting the interleukin-6 receptor to reduce unfavourable tissue remodelling after myocardial infarctionHelge Möllmann, Holger M Nef, Christian Troidl
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 21, 2013
Single-side renal sympathetic denervation in a hypertensive patient with a single kidneyOliver Dörr, Christian Hamm, Holger M Nef
Journal of the American College of Cardiology|December 16, 2014
Current status of bioresorbable scaffolds in the treatment of coronary artery diseaseJens Wiebe, Holger M Nef, Christian W Hamm
Current Opinion in Cardiology|October 9, 2015
Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers resultsJens Wiebe, Christian W Hamm, Holger M Nef
European Heart Journal|September 30, 2010
Anticoagulation in percutaneous coronary interventions: no man's land?Holger M Nef, Helge Möllmann, Christian W Hamm
European Heart Journal|September 12, 2013
Troponin: more lessons to learnChristoph Liebetrau, Holger M Nef, Christian W Hamm
Heart (British Cardiac Society)|June 12, 2010
Clinical pharmacology: antiplatelet therapy during surgeryHelge Möllmann, Holger M Nef, Christian W Hamm
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 17, 2016
Thebesian veins as drainage to the ventricle: A case reportNiklas F Boeder, Holger M Nef, Timm Bauer
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 21, 2023
DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIODAPTOR-RCTShigeru Saito, Holger M Nef, Mark Webster, et al.
Pageof 15